Local Anesthetic Toxicity — MCQs
Which local anesthetic is considered the most cardiotoxic?
A patient presented with rigidity, tremors, and trismus after being administered an anesthetic agent. Which anesthetic agent is most likely to have been administered?
What is the percentage of halothane that is metabolized in the human body?
A patient aged 28 years, was given epidural anesthesia with 15 ml of 1.5% Lignocaine with adrenaline for hernia surgery. He developed hypotension, respiratory arrest and became unconscious within 3 minutes, most probable cause will be:-
What is the primary cardiotoxic effect of bupivacaine?
Which of the following drugs is most commonly associated with ototoxicity?
Which of the following inhalation anesthetic agents is hepatotoxic?
Most cardiotoxic local anesthetic is:
A 25 year old male with roadside accident underwent debridement and reduction of fractured both bones right forearm under axillary block. On the second postoperative day the patient complained of persistent numbness and paresthesia in the right forearm and the hand. The commonest cause of this neurological dysfunction could be all of the following except :
26 year old female patient wanted epidural for labor analgesia. She was given 12ml of 0.25% bupivacaine immediately after this she developed hypotension, bradycardia, respiratory difficulty. Which of the following explains condition of the patient.
Local Anesthetic Toxicity Indian Medical PG Practice Questions and MCQs
Question 1: Which local anesthetic is considered the most cardiotoxic?
- A. Procaine
- B. Prilocaine
- C. Ropivacaine
- D. Bupivacaine (Correct Answer)
Explanation: ***Bupivacaine*** - **Bupivacaine** is an amide-type local anesthetic associated with significant **cardiotoxicity** due to its high lipid solubility and slow dissociation from cardiac sodium channels. - This can lead to severe **arrhythmias** and myocardial depression, making it particularly dangerous in systemic overdose. *Procaine* - **Procaine** is an ester-type local anesthetic with a relatively low potential for cardiotoxicity. - Its rapid metabolism by **plasma pseudocholinesterase** limits systemic exposure and reduces the risk of cardiac effects. *Prilocaine* - **Prilocaine** is an amide-type local anesthetic that is generally less cardiotoxic than bupivacaine. - Its primary concern is the potential to cause **methemoglobinemia** at higher doses, a side effect not directly related to cardiotoxicity. *Ropivacaine* - **Ropivacaine** is an amide-type local anesthetic developed as an alternative to bupivacaine with a reduced cardiotoxicity profile. - It exhibits a more favorable **therapeutic index** for cardiac effects due to its chemical structure and faster dissociation from cardiac sodium channels.
Question 2: A patient presented with rigidity, tremors, and trismus after being administered an anesthetic agent. Which anesthetic agent is most likely to have been administered?
- A. Halothane (Correct Answer)
- B. Nitrous Oxide (N2O)
- C. Thiopentone sodium
- D. Etomidate
Explanation: ***Halothane*** - The combination of **rigidity**, **tremors**, and **trismus** after an anesthetic agent suggests **malignant hyperthermia (MH)**, a rare but life-threatening inherited condition. - **Halothane (and other volatile anesthetics)**, along with succinylcholine, are known triggers for malignant hyperthermia. *Nitrous Oxide (N2O)* - While an anesthetic agent, **nitrous oxide** is not a known trigger for **malignant hyperthermia**. - It works by modulating **NMDA receptors** and does not typically cause rigidity, tremors, or trismus as a side effect. *Thiopentone sodium* - **Thiopentone sodium** is a **barbiturate** anesthetic and is not associated with triggering **malignant hyperthermia**. - Its effects primarily involve potentiation of **GABA-A receptors**, leading to sedation and hypnosis. *Etomidate* - **Etomidate** is a short-acting intravenous anesthetic that is not a known trigger for **malignant hyperthermia**. - It is typically associated with minimal cardiovascular depression but can cause **adrenocortical suppression** with prolonged use.
Question 3: What is the percentage of halothane that is metabolized in the human body?
- A. 50%
- B. 5%
- C. 2.50%
- D. 25% (Correct Answer)
Explanation: **Correct: 25%** - Approximately **25%** of administered halothane is metabolized in the liver, which is a relatively high percentage compared to other volatile anesthetics. - This extensive metabolism can lead to the formation of reactive intermediates, contributing to its potential for **hepatotoxicity** (halothane hepatitis). *Incorrect: 50%* - **50%** metabolism is significantly higher than what is observed for halothane and would imply even greater risk of significant metabolic byproduct accumulation and toxicity. - Most volatile anesthetics are metabolized to a much lesser extent, with desflurane having the least metabolism (<0.02%). *Incorrect: 5%* - **5%** metabolism is too low for halothane; while some volatile anesthetics like isoflurane fall into this range (~0.2-2%), halothane is known for its considerably higher metabolic rate. - A 5% metabolism rate would result in less concern for and incidence of **halothane hepatitis**. *Incorrect: 2.50%* - **2.50%** metabolism is an underestimation of halothane's metabolic activity within the body. - Anesthetic agents such as **enflurane** have a metabolism rate closer to this value (~2-5%), whereas halothane is much higher.
Question 4: A patient aged 28 years, was given epidural anesthesia with 15 ml of 1.5% Lignocaine with adrenaline for hernia surgery. He developed hypotension, respiratory arrest and became unconscious within 3 minutes, most probable cause will be:-
- A. High spinal block
- B. Intravascular injection of Lignocaine (Correct Answer)
- C. Anaphylaxis to lignocaine
- D. Total spinal block
Explanation: ***Intravascular injection of Lignocaine*** - Rapid onset (within 3 minutes) of **hypotension**, **respiratory arrest**, and **unconsciousness** after an epidural injection strongly indicates systemic toxicity from intravascular local anesthetic injection. - The large volume (15 mL) and concentration (1.5%) of lignocaine, especially with adrenaline, when injected directly into the bloodstream, can quickly lead to **central nervous system (CNS) depression** and cardiovascular collapse. *High spinal block* - A **high spinal block** typically results from a local anesthetic spreading too high in the intrathecal space, leading to widespread sympathetic blockade and paralysis of respiratory muscles. - While it causes hypotension and respiratory depression, the rapid onset and immediate unconsciousness, without prior signs of extensive motor block ascending, make intravascular injection a more probable cause for such acute and severe symptoms. *Anaphylaxis to lignocaine* - Anaphylaxis to local anesthetics is rare and would typically present with **urticaria**, **angioedema**, **bronchospasm**, and widespread erythema, which are not described. - While anaphylaxis can cause hypotension and cardiovascular collapse, the rapid onset of CNS depression leading to unconsciousness is more characteristic of local anesthetic systemic toxicity. *Total spinal block* - A **total spinal block** occurs when a local anesthetic meant for the epidural space accidentally enters the subarachnoid space and diffuses extensively. - This results in profound **hypotension**, **bradycardia**, and **apnea** due to high sympathetic and somatic nerve blockade; however, unconsciousness typically ensues after significant hypotension and hypoperfusion, not as immediately and severely as seen with direct intravascular injection of a toxic dose.
Question 5: What is the primary cardiotoxic effect of bupivacaine?
- A. Depressed pacemaker activity (Correct Answer)
- B. Toxic compound damaging myocardial cells
- C. Depressed neural control on heart
- D. Vascular thrombosis and Myocardial ischemia
Explanation: ***Depressed pacemaker activity*** - **Bupivacaine** is a potent **local anesthetic** that blocks voltage-gated **sodium channels** in myocardial cells with **high affinity** and **slow dissociation kinetics**. - This prolonged channel blockade leads to decreased cardiac excitability and **depressed automaticity** of pacemaker cells, particularly affecting the **SA node** and **His-Purkinje system**. - Results in slowing of the **heart rate**, **bradyarrhythmias**, **conduction blocks**, and potentially **ventricular arrhythmias** or **asystole**. - Bupivacaine is **more cardiotoxic** than other local anesthetics due to its **lipophilicity** and prolonged binding to cardiac sodium channels. *Toxic compound damaging myocardial cells* - While **bupivacaine** is cardiotoxic, its primary mechanism is not direct **cellular damage** through cytotoxic effects, oxidative stress, or cell membrane lysis. - The toxicity is predominantly due to **electrophysiological effects** on ion channels, interfering with normal cardiac conduction and contractility. *Depressed neural control on heart* - **Bupivacaine's** cardiotoxicity primarily affects the **myocardium directly** through sodium channel blockade, rather than indirectly through the **autonomic nervous system**. - Although high systemic concentrations can affect the **central nervous system** (causing seizures and CNS depression), the direct cardiac effects occur independently of neural influence. *Vascular thrombosis and Myocardial ischemia* - **Bupivacaine** cardiotoxicity does not typically involve formation of **thrombi** or mechanisms leading to **myocardial ischemia** through coronary artery occlusion. - Its effects are predominantly on the **electrical conduction system**, **myocardial contractility**, and **cardiac ion channels**, not the vascular supply to the heart.
Question 6: Which of the following drugs is most commonly associated with ototoxicity?
- A. Chloramphenicol
- B. Dapsone
- C. Isoniazid
- D. Gentamicin (Correct Answer)
Explanation: ***Gentamicin*** - **Gentamicin** is an **aminoglycoside antibiotic** well-known for its potential to cause **ototoxicity**, leading to hearing loss and/or vestibular dysfunction. - This adverse effect is often irreversible and can be dose-dependent or due to prolonged exposure. *Dapsone* - **Dapsone** is primarily used for **leprosy** and various dermatological conditions and is not commonly associated with ototoxicity. - Its main side effects include **hemolytic anemia**, methemoglobinemia, and peripheral neuropathy. *Isoniazid* - **Isoniazid** is a first-line drug for **tuberculosis**, and its most common adverse effects include **hepatotoxicity** and **peripheral neuropathy**. - While it can cause neurological side effects, ototoxicity is not a prominent or common association. *Chloramphenicol* - **Chloramphenicol** is an antibiotic known for serious side effects such as **bone marrow suppression** (aplastic anemia) and **gray baby syndrome** in neonates. - Ototoxicity is not a commonly recognized adverse effect of chloramphenicol.
Question 7: Which of the following inhalation anesthetic agents is hepatotoxic?
- A. Halothane (Correct Answer)
- B. Sevoflurane
- C. Isoflurane
- D. Desflurane
Explanation: ***Halothane*** - **Halothane** is known for its potential to cause **halothane hepatitis**, a severe and sometimes fatal form of liver damage. - This toxicity is typically due to the formation of reactive metabolites during its metabolism, which can lead to immune-mediated liver injury. *Sevoflurane* - **Sevoflurane** is generally considered to have a very low risk of hepatotoxicity. - While it can produce a small amount of inorganic fluoride, which was a concern with older halogenated anesthetics, its metabolic profile makes it much safer for the liver compared to halothane. *Isoflurane* - **Isoflurane** is metabolized to a very small extent (less than 0.2%), significantly reducing the risk of generating toxic metabolites that could harm the liver. - It is commonly used in clinical practice due to its favorable safety profile, including minimal hepatotoxicity. *Desflurane* - **Desflurane** has an even lower metabolism rate than Isoflurane, making it one of the safest inhaled anesthetics in terms of liver toxicity. - Its rapid onset and offset properties, coupled with its minimal metabolism, contribute to its low potential for hepatotoxic effects.
Question 8: Most cardiotoxic local anesthetic is:
- A. Procaine
- B. Lidocaine
- C. Ropivacaine
- D. Bupivacaine (Correct Answer)
Explanation: ***Bupivacaine*** - **Bupivacaine** is a **highly potent** local anesthetic known for its cardiotoxic effects due to its **lipophilicity** and strong binding to cardiac sodium channels. - Its **slow dissociation** from cardiac sodium channels at toxic plasma concentrations contributes to prolonged arrhythmias and myocardial depression. *Lidocaine* - **Lidocaine** has a **faster onset** and shorter duration of action compared to bupivacaine, making it less cardiotoxic. - While it can cause cardiac effects at high doses, it generally has a **safer cardiac profile** than bupivacaine and is often used as an antiarrhythmic. *Procaine* - **Procaine** is an **ester-type** local anesthetic, which means it is rapidly metabolized by plasma cholinesterases. - This rapid breakdown gives it a **short duration of action** and a **low potential for systemic toxicity**, including cardiotoxicity. *Ropivacaine* - **Ropivacaine** is a **less lipophilic** analog of bupivacaine, designed to have a reduced cardiotoxicity profile. - While it still has potential for cardiotoxicity at very high doses, it demonstrates a **higher therapeutic index** for cardiac rhythm compared to bupivacaine.
Question 9: A 25 year old male with roadside accident underwent debridement and reduction of fractured both bones right forearm under axillary block. On the second postoperative day the patient complained of persistent numbness and paresthesia in the right forearm and the hand. The commonest cause of this neurological dysfunction could be all of the following except :
- A. Tourniquet pressure
- B. Crush injury to the hand and lacerated nerves
- C. A tight cast or dressing
- D. Systemic toxicity of local anaesthetics (Correct Answer)
Explanation: ***Systemic toxicity of local anaesthetics*** - This typically presents with **acute neurological symptoms** (e.g., seizures, metallic taste, tinnitus) or **cardiovascular collapse** during or immediately after local anesthetic administration. - Persistent numbness and paresthesia on the second postoperative day are **not characteristic** of systemic local anesthetic toxicity, which is a transient effect. *Tourniquet pressure* - **Prolonged or excessively high tourniquet pressure** can lead to nerve ischemia and damage, causing paresthesia and numbness in the limb distal to the tourniquet. - These symptoms often persist for some time post-operatively, consistent with the patient's presentation. *Crush injury to the hand and lacerated nerves* - The initial **roadside accident** involving a severely injured limb could directly cause **nerve lacerations or crush injuries**, leading to immediate and persistent neurological deficits like numbness and paresthesia. - Such direct nerve trauma would manifest immediately and continue post-operatively, aligning with the patient's complaints. *A tight cast or dressing* - A **tight cast or dressing** applied to the forearm can compress nerves, leading to **ischemia and neuropathy**. - This mechanical compression can cause persistent numbness and paresthesia, which might become more noticeable as swelling increases post-surgery.
Question 10: 26 year old female patient wanted epidural for labor analgesia. She was given 12ml of 0.25% bupivacaine immediately after this she developed hypotension, bradycardia, respiratory difficulty. Which of the following explains condition of the patient.
- A. Vasovagal attack
- B. Drug allergy
- C. Total spinal anaesthesia (Correct Answer)
- D. Systemic toxicity
Explanation: ***Total spinal anaesthesia*** - **Total spinal anesthesia** occurs when a local anesthetic, intended for epidural space, is inadvertently injected into the **subarachnoid space**, leading to extensive blockade of spinal nerves. - This results in rapid onset of **hypotension** and **bradycardia** due to sympathetic blockade, and **respiratory difficulty** from phrenic nerve paralysis. *Vasovagal attack* - A **vasovagal attack** is typically characterized by transient hypotension and bradycardia, usually in response to pain or anxiety. - It would not explain the rapid onset of **respiratory difficulty** or the profound cardiovascular collapse seen after anesthetic injection. *Drug allergy* - A **drug allergy** (anaphylaxis) would present with skin manifestations (hives, angioedema), bronchospasm, and potentially cardiovascular collapse. - While hypotension and bradycardia can occur, the immediate onset of **severe respiratory difficulty** in the absence of other allergic signs points away from an allergic reaction to bupivacaine. *Systemic toxicity* - **Systemic toxicity** from local anesthetics like bupivacaine arises from absorption into the bloodstream, leading to central nervous system (CNS) and cardiovascular effects. - Initial CNS signs include **tinnitus**, perioral numbness, and seizures, followed by cardiovascular depression; the rapid and severe onset of symptoms, especially respiratory distress, is more typical of **total spinal anesthesia**.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free